Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Leukemia
Related studies linked through entity extraction aliases.
PR1 Vaccination in Myelodysplastic Syndrome (MDS)
- Status
- TERMINATED
- Phase
- PHASE2
Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?
- Status
- COMPLETED
- Phase
- NA
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis
- Status
- COMPLETED
- Phase
- NA
Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial
- Status
- COMPLETED
- Phase
- N/A
DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129)
- Status
- COMPLETED
- Phase
- PHASE3
Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia
- Status
- WITHDRAWN
- Phase
- PHASE1
Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias
- Status
- TERMINATED
- Phase
- PHASE1
Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML
- Status
- TERMINATED
- Phase
- PHASE2
FTS Study in Patients With Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
JVRS-100 for the Treatment of Patients With Relapsed or Refractory Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Trial of Alemtuzumab and Rituximab in Patients With Previously Untreated CLL
- Status
- COMPLETED
- Phase
- PHASE2
Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen
- Status
- COMPLETED
- Phase
- PHASE2